Tyra Biosciences, Inc.
Tyra Biosciences, Inc. is tracked here for clinical trial milestones, SEC filings and earnings dates. Focus area: Pharmaceutical Preparations.
The next scheduled catalyst is Next quarterly earnings (projected) on October 26, 2026, a projected date rather than a confirmed one. There are 7 upcoming events on record.
Cash runway is approximately 6.8 months based on the most recent reported cash position and quarterly operating burn as of 2026-06-30.
Track TYRA alongside other companies. Add it to a watchlist and see every catalyst on one calendar.
Open TYRA in the tracker| Date | Event | Type | Phase |
|---|---|---|---|
| September 15, 2026 | 8-K filed: Other event | Filing | — |
| September 9, 2026 | 8-K filed: Other event | Filing | — |
| August 4, 2026 | Quarterly results filed (8-K) | Earnings | — |
| May 13, 2026 | Quarterly results filed (8-K) | Earnings | — |
| April 17, 2026 | 8-K filed: Leadership change | Corporate | — |
| April 2, 2026 | 8-K filed: Leadership change | Corporate | — |
| March 4, 2026 | 8-K filed: Other event | Filing | — |
| March 2, 2026 | Quarterly results filed (8-K) | Earnings | — |
| December 1, 2025 | 8-K filed: Leadership change | Corporate | — |
| November 5, 2025 | Quarterly results filed (8-K) | Earnings | — |
| August 22, 2025 | 8-K filed: Other event | Filing | — |
| August 14, 2025 | Quarterly results filed (8-K) | Earnings | — |
| June 30, 2025 | 8-K filed: Other event | Filing | — |
| May 15, 2025 | A Relative Bioavailability and Food Effect Study of TYRA-300-B01 Capsule and Tablet Formulations in Healthy Adult Participants | Trial Milestone | Phase 1 |
| May 8, 2025 | Quarterly results filed (8-K) | Earnings | — |
Trial milestones come from the ClinicalTrials.gov v2 API, filings from SEC EDGAR, and financial figures from SEC XBRL company facts. Dates marked est. are projected rather than company-confirmed. This is an information tool, not investment advice — verify anything you act on against the linked primary source.
Last updated 2026-10-14.